BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
Human serum albumin therapy confers neurobehavioral and histopathologic neuroprotection in adult stroke models. We investigated whether albumin might also be neuroprotective in ischemic brain injury ...
In the quest to advance therapeutic development, the creation of transgenic mouse models expressing human proteins has become increasingly prevalent. These models have a unique ability to address gaps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback